🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The efficacy and safety of Telmisartan capsule in patients with essential h...
Status
Completed
Location
Multiple Locations
Start Date
1998-09
Trial ID
NCT02177448
The purpose of this study is to determine the safety and efficacy of HB-1, ...
Status
Suspended
Location
Paratus Clinical Research Canberra
Start Date
2024-10-29
Trial ID
NCT06483789
An investigator initiated and conducted, multicentre, international, double...
Status
Completed
Location
Liverpool Hospital
Start Date
2017-09-28
Trial ID
NCT02699645
Treatments Being Tested
TRIDENT Main Study: TRIDENT is a multicentre, international, double-blinde...
Status
Terminated
Location
Liverpool Hospital
Start Date
2018-08-09
Trial ID
NCT03783754
Treatments Being Tested
This is a multi-centre, randomised, double-blind, active-controlled, parall...
Status
Completed
Location
1348.2.020 Boehringer Ingelheim Investigational Site
Start Date
2013-07
Trial ID
NCT01911780
Treatments Being Tested
Parkinson's disease (PD) is currently the fastest-growing neurological cond...
Status
Recruiting
Location
UCLH
Start Date
2025-09-12
Trial ID
NCT07207057
Treatments Being Tested
A Sub-Study of an investigator initiated and conducted, multicentre, intern...
Status
Terminated
Location
Liverpool Hospital
Start Date
2020-02-27
Trial ID
NCT03785067
Treatments Being Tested
The purpose of this study is to determine whether long-term treatment with ...
Status
Terminated
Location
Mazankowski Alberta Heart Institute
Start Date
2011-06
Trial ID
NCT01202721
Treatments Being Tested
The purpose of this study is to determine if telmisartan, an FDA approved b...
Status
Completed
Location
Emory University
Start Date
2015-04
Trial ID
NCT02471833
Treatments Being Tested
This is a multi-centre, randomised, double-blind, active-controlled, parall...
Status
Completed
Location
1348.1.015 Boehringer Ingelheim Investigational Site
Start Date
2013-11
Trial ID
NCT01975246
Treatments Being Tested